Disposition and metabolism of [14C]-galunisertib, a TGF-βRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics.
about
Disposition and metabolism of [14C]-galunisertib, a TGF-βRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Disposition and metabolism of ...... galunisertib pharmacokinetics.
@en
Disposition and metabolism of ...... galunisertib pharmacokinetics.
@nl
type
label
Disposition and metabolism of ...... galunisertib pharmacokinetics.
@en
Disposition and metabolism of ...... galunisertib pharmacokinetics.
@nl
prefLabel
Disposition and metabolism of ...... galunisertib pharmacokinetics.
@en
Disposition and metabolism of ...... galunisertib pharmacokinetics.
@nl
P2093
P2860
P1433
P1476
Disposition and metabolism of ...... galunisertib pharmacokinetics.
@en
P2093
Colin Miles
Ivelina Gueorguieva
Jessica Rehmel
Kenneth C Cassidy
William J Ehlhardt
P2860
P304
P356
10.1080/00498254.2017.1323137
P407
P577
2017-05-16T00:00:00Z